A first-in-class anticancer dual HDAC2/FAK inhibitors bearing hydroxamates/benzamides capped by pyridinyl-1,2,4-triazolesMuhamad Mustafa, Gamal El‐Din A. Abuo‐Rahma|European Journal of Medicinal Chemistry|2021Cited by 41